Shree Ganesh Remedies Limited

NSE: SGRL · Unclassified

₹625.85-0.91%06 Nov 2026

Ask the data

Instant answers about Shree Ganesh Remedies Limited — computed from its filings, no language model

Market cap—

Current price₹625.85

High / Low₹736 / ₹501

P/E—

P/B—

Book value—

ROE—

ROCE—

Debt / equity—

Dividend yield—

EPS (TTM)—

Face value—

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY22†	FY23†	FY24†	FY25†	FY26†
Revenue	71.3	90.2	125.4	108.6	109.3
EBITDA	17.9	23.5	41.1	39.2	35.0
Operating margin	25.2%	26.0%	32.8%	36.1%	32.0%
Interest	0.1	0.4	0.2	2.1	3.6
Depreciation	3.3	3.7	6.2	9.6	10.5
Profit before tax	18.0	22.6	38.8	31.3	24.0
Tax	4.6	5.6	10.1	8.2	6.2
Net profit	13.4	17.0	28.7	23.1	17.8

Quarterly performance

last 24 quarters · ₹ crore

showing latest 8 of 24 periods

	MAR '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†	MAR '23†	JUN '23†	SEP '23†	DEC '23†	MAR '24†	JUN '24†	SEP '24†	DEC '24†	MAR '25†	JUN '25†	SEP '25†	DEC '25†	MAR '26†	JUN '26†
Revenue	26.1	13.3	15.4	12.6	17.0	21.1	20.6	17.6	21.3	22.0	29.3	26.7	33.4	28.0	37.3	24.8	32.3	27.1	24.4	24.7	30.3	21.1	33.2	14.4
Operating profit	4.7	3.2	5.1	3.1	4.4	5.8	4.7	4.2	5.6	5.4	8.3	6.8	9.2	8.2	16.9	8.1	11.3	9.9	9.9	7.3	9.6	6.7	11.4	3.4
Operating margin	18.0%	23.9%	33.1%	24.2%	26.2%	27.4%	22.6%	24.1%	26.4%	24.4%	28.2%	25.3%	27.6%	29.4%	45.4%	32.8%	35.0%	36.6%	40.4%	29.6%	31.7%	31.9%	34.2%	23.3%
Other income	2.5	0.6	0.1	1.1	0.4	0.9	1.1	0.7	0.7	1.4	0.4	0.7	0.8	1.1	1.3	0.6	0.2	0.7	2.3	0.7	0.7	0.7	1.0	0.9
Interest	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.4	1.0	0.9	1.0	0.7	0.9	0.3
Depreciation	1.2	0.2	1.2	0.8	0.9	1.0	0.6	0.8	0.9	1.0	1.0	1.0	1.4	1.9	1.9	2.0	2.4	2.7	2.4	2.4	2.6	2.7	2.8	2.4
Profit before tax	5.9	3.5	4.0	3.3	3.9	5.6	5.2	3.9	5.3	5.8	7.6	6.5	8.6	7.4	16.2	6.3	8.7	7.5	8.8	4.6	6.7	4.0	8.7	1.5
Tax	1.5	0.7	1.0	0.9	0.9	1.4	1.4	1.0	1.4	1.4	1.8	1.7	2.0	2.6	3.7	1.7	2.2	2.1	2.2	1.1	1.8	0.9	2.5	0.4
Net profit	4.4	2.8	3.0	2.3	3.0	4.2	3.8	2.9	3.9	4.3	5.9	4.8	6.5	4.8	12.6	4.7	6.4	5.4	6.6	3.5	5.0	3.1	6.3	1.1
EPS ₹	4.95	2.77	3.03	2.34	3.02	3.50	3.20	2.39	3.28	3.62	4.78	3.86	5.32	3.84	10.01	3.62	4.98	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Revenue YoY	—	—	-41.0%	—	—	59.4%	33.8%	39.7%	25.3%	4.1%	42.7%	51.5%	57.1%	27.2%	27.3%	-7.3%	-3.2%	-3.3%	-34.6%	-0.4%	-6.2%	-22.0%	35.9%	-41.8%
Profit YoY	—	—	-31.8%	—	—	51.6%	26.7%	22.6%	30.5%	3.6%	52.9%	65.5%	66.2%	10.3%	114.5%	-2.1%	-2.0%	13.1%	-47.6%	-25.8%	-22.7%	-42.9%	-5.0%	-67.5%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 20 periods

	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Net margin	19.2%	19.0%	18.8%	18.3%	18.4%	18.4%	18.9%	19.0%	19.3%	18.7%	22.9%	23.2%	23.2%	23.9%	21.3%	20.2%	19.2%	18.0%	16.3%	15.6%
EBITDA margin	27.1%	27.8%	25.2%	25.1%	25.2%	24.4%	26.0%	26.2%	26.6%	27.6%	32.8%	34.4%	36.4%	38.1%	36.1%	35.4%	34.5%	33.4%	32.0%	31.4%
Interest coverage	114.08	121.36	121.00	69.93	53.63	54.00	57.45	115.36	317.44	377.62	204.95	78.22	43.01	31.28	15.97	11.91	9.40	7.59	7.73	8.10

Balance sheet

equity vs borrowings over time · ₹ crore

Not filed yet.

Cash flow

annual · ₹ crore · line = free cash flow

Not filed yet.

Where the assets sit

No balance sheet filed yet.

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Shree Ganesh Remedies Limited	—	625.85	—	—	—

StoxGud checklist: Bearish setup · 1/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.5%

6 months—

1 year—

3Y CAGR—

5Y CAGR—

10Y CAGR—

50-day avg₹661.77

200-day avg—

RSI (14)37

FAQs

What is the share price of Shree Ganesh Remedies Limited?

Shree Ganesh Remedies Limited (SGRL) closed at ₹625.85 on NSE on 06 Nov 2026.

How fast is Shree Ganesh Remedies Limited growing?

Shree Ganesh Remedies Limited: revenue has compounded at 6.6% a year over three years; net profit at 1.4% a year. Latest-quarter revenue is down 41.8% year on year, profit down 67.5%.

How profitable is Shree Ganesh Remedies Limited?

On a trailing-twelve-month basis operating margin 31.4%, net margin 15.6%.

How much debt does Shree Ganesh Remedies Limited have?

Debt to equity isn't meaningful for Shree Ganesh Remedies Limited (banks borrow as part of their business) or isn't filed yet.

Shree Ganesh Remedies Limited's results are not in NSE's XBRL filings, so these are its standalone quarterly results as published on BSE (†), ₹ crore, from MAR '20; full years are summed from the quarters. No balance sheet or cash flow is available from this source. Information only, not investment advice.